logo
Select company
Select metric
$ -46.1MNet Cash Flow - Investing
VS
Market
44
Sector
22
Industry
13
History
34
$ 14.3Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information

Ticker

SNDX

Company Name

SYNDAX PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SYNDAX PHARMACEUTICALS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SNDX - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ -46.1M
3/31/2025$ -26.23M
12/31/2024$ -219.78M
9/30/2024$ 32.91M
6/30/2024$ -13.86M
3/31/2024$ -1.71M
12/31/2023$ 117.61M
9/30/2023$ -3.73M
6/30/2023$ -50.6M
3/31/2023$ -174.46M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Investing stands at $ -71.79M.
  • Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average CF - Investing has been $ -63.23M.
  • The median CF - Investing for SYNDAX PHARMACEUTICALS INC during this period was $ -48.35M
  • SYNDAX PHARMACEUTICALS INC reached its highest CF - Investing over the past 5 years at $ 117.61M.
  • The lowest CF - Investing recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe $ -219.78M

SYNDAX PHARMACEUTICALS INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
NRIX : NURIX THERAPEUTICS INC $ 6.69MURGN : UROGEN PHARMA LTD $ -43.69MTBPH : THERAVANCE BIOPHARMA INC $ -7.34MZVRA : ZEVRA THERAPEUTICS INC $ -14.35MKURA : KURA ONCOLOGY INC $ -91.89MSAGE : SAGE THERAPEUTICS INC $ 254.43MGYRE : GYRE THERAPEUTICS INC $ -5.47MNKTR : NEKTAR THERAPEUTICS $ 199.63MEYPT : EYEPOINT PHARMACEUTICALS INC $ 8.1MZYME : ZYMEWORKS INC $ 86.97M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

SNDX - Net Cash Flow - Investing, Last 5 years

$ -219.78M

Minimum

Dec 31, 2024

$ 117.61M

Maximum

Dec 31, 2023

$ -63.23M

Average

$ -48.35M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M